ARTICLE | Clinical News
Connetics regulatory update
March 31, 1997 8:00 AM UTC
CNCT received U.S. Patent No. 5,614,192 covering its T cell receptor (TCR) vaccine technology. The patent claims TCR peptides and functional derivatives encompassing the TCR second complementarity de...